Login
Navigate Fool.com
Will FPRX beat
the market?
Community Rating: 5 Stars: The Best

14.92 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.24
Previous Close $14.92
Daily Range $14.28 - $15.43
52-Week Range $8.02 - $23.33
Market Cap $318.7M
P/E Ratio -2.80
Dividend (Yield) $0.00 (0.0%)
Volume 190,631
Average Daily Volume 282,737
Current FY EPS -$1.60

How do you think FPRX
will perform against the market?

Top FPRX Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

Big Pharma's Not-So-Hidden Secret to Success

Organic pipeline innovation and acquisitions aside, this has been the biggest driver of Big Pharma's success in recent years.

This Week in Biotech: Endocyte Doubles, Intercept Wobbles, and Geron Gets Smacked Again

Two regulatory actions, four mammoth clinical study updates, and an intriguing immunotherapeutic collaboration, are this week's most important biotech stories.

Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal

Five Prime, Bristol-Myers Squibb cut $350M immuno-oncology deal.

Why Schawk, Kandi Technologies, and Five Prime Therapeutics Are Today's 3 Best Stocks

The S&P 500 surges following the Crimean vote and strong U.S. economic data while Schawk, Kandi Technologies, and Five Therapeutics all gain at least 22%!

Why Five Prime Therapeutics Inc. Shares Surged

Five Prime lands a collaborative deal with a pharmaceutical giant. Find out what this new deal entails and how Five Prime will benefit.

Today's Top Biotech Stories: Five Prime, Bristol-Myers Squibb, Intercept, and Gilead Sciences

Five Prime, Bristol-Myers Squibb, Intercept Pharmaceuticals, and Gilead Sciences could be the top biotech stories to follow this morning. Here's why.

Five Prime Therapeutics Gets a New CFO

Biotech also appointed its senior VP and chief business officer to the board of directors.

See More FPRX News...

Sector

Industry

Five Prime Therapeutics (FPRX) Description

Website: http://www.fiveprime.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks